Accelerating DTx Market Access: Forecasting Future Regulatory and Reimbursement Pathways in Canada
Alexis Sciuk
Global Market Access Policy Strategist
Pfizer
Mia Spiegelman
Vice-President of Regulatory Affairs
Medtech Canada
Ben King
Director, Digital Health & Innovation
Santis Health
- Defining digital therapeutics
- Examining examples of how DTx and the potential to benefit different patient populations
- Developing a DTx access strategy with insights on how regulators, public and private payers are viewing these innovations in Canada
- Forecasting the future regulatory and reimbursement landscape in Canada
- Assessing how the US and Europe are approaching reimbursement for digital therapeutics
- Forecasting the future regulatory and reimbursement landscape in Canada
- Examining what steps are being taken towards the development of digital formularies
- Examining the role of digital therapeutics in the RWD ecosystem